Genomics Reporting Implementation Guide
3.0.1-SNAPSHOT - Ballot International flag

Genomics Reporting Implementation Guide, published by HL7 International / Clinical Genomics. This guide is not an authorized publication; it is the continuous build for version 3.0.1-SNAPSHOT built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of and changes regularly. See the Directory of published versions

Example Observation: ROS1-Fusion-therapuTrial

Generated Narrative: Observation

ResourceObservation "ROS1-Fusion-therapuTrial"

Profile: Therapeutic Implication

status: final

category: Laboratory (Observation Category Codes#laboratory), Genetics (diagnosticServiceSectionId#GE)

code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)

subject: Patient/somaticPatient " HAMSBURG"

effective: 2023-02-01

performer: Practitioner/pathologistPractitioner " DOLIN"

derivedFrom: Observation/ROS1-Fusion-var


code: Associated phenotype (LOINC#81259-4)

value: Non-small cell lung cancer (SNOWMED CT#254637007 "Non-small cell lung cancer (disorder)")


code: Medication assessed (LOINC#51963-7)

value: Taletrectinib ()


code: Associated Therapy (To Be Determined Codes#associated-therapy)

value: A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of Taletrectinib in Patients With Advanced or Metastatic ROS1 Positive NSCLC and Other Solid Tumors ( "NCT04919811")


Related Artifact for Observation component:

code: Level of evidence (LOINC#93044-6)

value: Tier I - Level A ()